0 penilaian0% menganggap dokumen ini bermanfaat (0 suara)
389 tayangan17 halaman
Clinical trials are undertaken at various stages also known as 'phases' They include trials on healthy humans; trials on patients with a disease; and studies conducted after the launch of a new product (PMS) It is this sector that is driving the growth in Clinical Research in India. India is one of the top 3 countries where companies plan to spend the most R and D dollars over the next 3 years.
Clinical trials are undertaken at various stages also known as 'phases' They include trials on healthy humans; trials on patients with a disease; and studies conducted after the launch of a new product (PMS) It is this sector that is driving the growth in Clinical Research in India. India is one of the top 3 countries where companies plan to spend the most R and D dollars over the next 3 years.
Hak Cipta:
Attribution Non-Commercial (BY-NC)
Format Tersedia
Unduh sebagai PDF, TXT atau baca online dari Scribd
Clinical trials are undertaken at various stages also known as 'phases' They include trials on healthy humans; trials on patients with a disease; and studies conducted after the launch of a new product (PMS) It is this sector that is driving the growth in Clinical Research in India. India is one of the top 3 countries where companies plan to spend the most R and D dollars over the next 3 years.
Hak Cipta:
Attribution Non-Commercial (BY-NC)
Format Tersedia
Unduh sebagai PDF, TXT atau baca online dari Scribd
Clinical Research is a scientific study of the effects, risks,
efficacy and benefits of a medicine. They are undertaken at
various stages also known as 'phases', and include: trials on healthy humans; trials on patients with a disease; and studies conducted after the launch of a new product (PMS) to monitor safety and side effects during large-scale use.
Clinical trials are conducted by pharmaceutical companies or
Contract Research Organization (CRO’s) / Site Management Organization (SMO’s) on their behalf. It is this sector that is driving the growth in Clinical Research in India. PHASE I
PHASE II
PHASE III
MARKETING OF THE DRUG
POST MARKETING SURVEILLANCE
OR PERIODIC SAFETY UPDATE REVIEW
PHASE I – HUMAN PHARMACOLOGY TRIALS
PHASE II – THERAPEUTIC EXPLORATORY TRIALS PHASE III – THERAPEUTIC CONFIRMATORY TRIALS MARKETING OF THE DRUG PHASE IV – POST MARKETING SURVEILLANCE / PERIODIC SAFETY UPDATE REVIEWS The total worldwide R&D spending for pharmaceutical and biotech companies (Pharma) in 2007 was $117 Billion, of which 70% represented development costs. This spending is expected to grow at 11% annually and will be $218 billion in 2013. The CRO market for Phase 1 through 4 trials represented about $7.8 Billion in 2007 and is projected to grow to $17.2 Billion in 2013. Clinical Trials.gov currently has 86,860 trials with locations in 172 countries. Continue to spread in more & more countries. Six therapy areas, oncology, central nervous system, respiratory, endocrinology, cardiovascular and infectious diseases, account for 68% of all clinical trial protocols and 74% of all sites analyzed. India is home to more than one billion people. India has a population of appx. 30 million with cardiovascular diseases , 25 million with type – 2 diabetes and 10 million with major psychiatric disorders. India is one of the top 3 countries where companies plan to spend the most R & D dollars over the next 3 years. India’s pharmaceutical industry is the second largest in Asia, growing by 9% annually. Excellent quality management, Technology and infrastructure available in India. Over 200 hospitals serving as sites for clinical trials, India is emerging as one of the fastest recruiter of subjects across the world. Some of the top medical/technical universities in Asia. continue.. The clinical community is populated with English speaking, western-trained graduates. Sophisticated technological infrastructure. 100 million plus English speaking/trained professionals(Largest outside US). Over 2million science postgraduates and growing… Large pool of treatment naïve patients from multi ethnic and multiracial backgrounds. Better patient recruitment, retention and compliance. Participants generally benefit, as the trials conducted in India, mostly in phase II -IV, provide improved care and cost savings as procedures and drugs are provided at no charge. Captive Research Most Big Pharma have set up captive centers that are conducting multicentre trials in India. They are either operating through a complete in-house model with their own employees and infrastructure or in-sourcing FTEs from MNC/Indian CROs to carry out their clinical trial operations in the country. MNC Ongoing Trials (between Operative model of 2004-09 ) Captive Research
Pfizer 61 Inhouse + Insource
GlaxoSmithKline 59 Inhouse Eli Lilly 34 Inhouse + Insource Novartis 32 Inhouse Sanofi -Aventis 42 Inhouse Indian CR market will grow to US $1.5 billion in value by 2010. Other Site Staff
Investigator
Supply CRO Staff Demand
Sponsor Staff
0 1000 2000 3000 4000 5000 6000 7000
Fastest growing segment in the healthcare / pharmaceutical industry Excellent Opportunity to Develop Combination of Technical and Management Skills Part of the Global Growth Opportunity Wider Job Horizon Rapidly Growing Opportunities…and growing (internal and external) Attractive Compensation and future growth Higher Job Satisfaction Continuous Training Opportunities International Opportunities The clinical research industry is credited for a new and increasing awareness and emphasis on the need for education and training. However, although the industry may be observing an upward trend in support of such, it is obvious that resistance remains. Until the clinical research industry requires and/or standardizes such training and education, it remains optional to those coming into our industry and we will continue to see many who are uneducated and lack the necessary skills to fulfill their defined roles. As an industry, education and training standards should be raised. The industry should require that professionals in this industry be trained and educated to perform the roles expected of them. DETAILS
Course: Advanced Post Graduate Diploma in Clinical
Research Duration : 6 months Methodology: Regular Classroom studies for 3 months + Practical training for next 3 months in chosen field of CDM/PV/QA-QC will be provided. IICR’s PGD-CR program is a complete package of theory and practical training. Classroom teaching by eminent faculty involving Lectures and Power Point Presentations is to provide complete understanding of the clinical research. Practical training into CRO for 3 months in chosen specialisation of Clinical Data Management/ Pharmacovigilance / QA-QC will be provided as per the industry demands. Through this students enables themselves to fulfil the demand of trained manpower into the industry. Pharmaceutical Companies Clinical CROs (Contract Research Organizations) BA/BE Centers SMOs (Site Management Organizations) Data Management CROs IT Companies in Healthcare / Clinical Domain •EDC Service Providers •Central Laboratories •Packaging & Labeling & Contract Manufacturers •Investigator & Site Staff •Training Centers. Clinical Trial Assistant (CTA) Clinical Research Associate (CRA) Senior CRA Phase I / II / III / IV Trial Clinical Team Leader Project Management Project Manager Drug Development Planning Senior Project Manager Monitoring Manager Medical & Regulatory Source Data Verification Manager –Safety / Patents Safety Reporting Manager Quality Assurance Regulatory Approval Medical Director QA Audits Associate Director Clinical Business Development Associate Director –Projects Director –Business Development Director / Head (Clinical Operations) General Manger / CEO / President
The secret of success in life is for a man to be ready for his